Severe Cyanoacrylate Granuloma Following Cyanoacrylate Closure for Varicose Veins in a Patient with Immune Modulation: A Case Report.

IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE
Annals of vascular diseases Pub Date : 2026-01-01 Epub Date: 2026-03-31 DOI:10.3400/avd.cr.25-00144
Takahiro Imai, Daisuke Harada, Yoichi Mizutani, Soutarou Katsui
{"title":"Severe Cyanoacrylate Granuloma Following Cyanoacrylate Closure for Varicose Veins in a Patient with Immune Modulation: A Case Report.","authors":"Takahiro Imai, Daisuke Harada, Yoichi Mizutani, Soutarou Katsui","doi":"10.3400/avd.cr.25-00144","DOIUrl":null,"url":null,"abstract":"<p><p>We report a case of severe cyanoacrylate granuloma (CAG) that developed shortly after cyanoacrylate closure (CAC) in a patient receiving dupilumab. A 74-year-old female had an uneventful postoperative course until the day before initiation of dupilumab; however, on postoperative day (POD) 16, 1 day after starting dupilumab, she developed fever and painful inguinal nodules. Computed tomography revealed multiple subcutaneous nodules without abscess formation. Despite systemic corticosteroids and antihistamines, the lesions progressed, requiring repeated bilateral excisions through POD 93. This case suggests that immune modulation at the time of cyanoacrylate exposure may influence the severity and progression of granulomatous inflammation after CAC.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"19 1","pages":""},"PeriodicalIF":0.6000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13043239/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of vascular diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3400/avd.cr.25-00144","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/31 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

We report a case of severe cyanoacrylate granuloma (CAG) that developed shortly after cyanoacrylate closure (CAC) in a patient receiving dupilumab. A 74-year-old female had an uneventful postoperative course until the day before initiation of dupilumab; however, on postoperative day (POD) 16, 1 day after starting dupilumab, she developed fever and painful inguinal nodules. Computed tomography revealed multiple subcutaneous nodules without abscess formation. Despite systemic corticosteroids and antihistamines, the lesions progressed, requiring repeated bilateral excisions through POD 93. This case suggests that immune modulation at the time of cyanoacrylate exposure may influence the severity and progression of granulomatous inflammation after CAC.

免疫调节患者静脉曲张用氰基丙烯酸酯封闭后的严重氰基丙烯酸酯肉芽肿一例报告。
我们报告一例严重的氰基丙烯酸酯肉芽肿(CAG),在接受杜匹单抗的患者氰基丙烯酸酯闭合(CAC)后不久发展。一名74岁的女性在开始使用杜匹单抗的前一天有一个平稳的术后过程;然而,在开始使用dupilumab后第1天,即术后第16天,患者出现发烧和腹股沟结节疼痛。电脑断层显示多个皮下结节,无脓肿形成。尽管全身使用皮质类固醇和抗组胺药,病变仍在进展,需要通过POD 93进行多次双侧切除。本病例提示,氰基丙烯酸酯暴露时的免疫调节可能影响CAC后肉芽肿性炎症的严重程度和进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Annals of vascular diseases
Annals of vascular diseases PERIPHERAL VASCULAR DISEASE-
自引率
0.00%
发文量
41
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书